2026 Vol.44, N°5 - Table of contents
May 2026
Review
CER19796
2026,44,5
Pg. 0883-0894
Free to view
Gout: one year in review 2026
L. Punzi, C. Baggio, P. Galozzi, M. Lorenzin, G. Cozzi, A.C. Damasco, P. Sfriso, F. Oliviero, R. Ramonda
DOI: https://doi.org/10.55563/clinexprheumatol/9xhnbu
L. Punzi, C. Baggio, P. Galozzi, M. Lorenzin, G. Cozzi, A.C. Damasco, P. Sfriso, F. Oliviero, R. Ramonda
DOI: https://doi.org/10.55563/clinexprheumatol/9xhnbu
Full Papers
CER19192
2026,44,5
Pg. 0895-0902
Free to view
Parvovirus B19 infection with rheumatologic manifestations: results from a multicentre Italian study
F. Aldegheri, R. Bixio, A. Volpe, A. Giollo, M. Fornaro, A. Morciano, M. Orlandi, C. Benini, A. Biglia, E. Bozzalla Cassione, A. Ortolan, D. Bertelle, G. Orsolini, F. Ruzzon, M. Salvato, A. Carletto, F. Campanaro, E. Chessa, E. Fracassi, I. Galvagni, G. Adami
DOI: https://doi.org/10.55563/clinexprheumatol/p64ofs
F. Aldegheri, R. Bixio, A. Volpe, A. Giollo, M. Fornaro, A. Morciano, M. Orlandi, C. Benini, A. Biglia, E. Bozzalla Cassione, A. Ortolan, D. Bertelle, G. Orsolini, F. Ruzzon, M. Salvato, A. Carletto, F. Campanaro, E. Chessa, E. Fracassi, I. Galvagni, G. Adami
DOI: https://doi.org/10.55563/clinexprheumatol/p64ofs
CER18935
2026,44,5
Pg. 0903-0912
The application value of peripheral plasmablasts in the assessment of disease activity and treatment response in systemic lupus erythematosus.
L. Wan, J. Guo, A. Sun, H. Chen, B. Hu, C. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/xsjjih
L. Wan, J. Guo, A. Sun, H. Chen, B. Hu, C. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/xsjjih
CER19029
2026,44,5
Pg. 0913-0924
Belimumab modulates type I interferon signalling in the treatment of systemic lupus erythematosus
T. Xun, Q. Ding, Y. Ye, X. Yang, L. Mo
DOI: https://doi.org/10.55563/clinexprheumatol/03t59o
T. Xun, Q. Ding, Y. Ye, X. Yang, L. Mo
DOI: https://doi.org/10.55563/clinexprheumatol/03t59o
CER18886
2026,44,5
Pg. 0925-0937
Free to view
High sensitivity measurement of circulating interferon proteins in systemic lupus erythematosus
Y.-J. Huang, C.M. Bottomley, R.T. Maughan, A. Field, G.H. Leung, L. Lightstone, T.D. Cairns, T. Turner-Stokes, M.B. Condon, J.E. Peters, M. Botto, M.C. Pickering
DOI: https://doi.org/10.55563/clinexprheumatol/lyd5es
Y.-J. Huang, C.M. Bottomley, R.T. Maughan, A. Field, G.H. Leung, L. Lightstone, T.D. Cairns, T. Turner-Stokes, M.B. Condon, J.E. Peters, M. Botto, M.C. Pickering
DOI: https://doi.org/10.55563/clinexprheumatol/lyd5es
CER19054
2026,44,5
Pg. 0938-0947
MXRA5 is identified and validated as a key gene related to epithelial-mesenchymal transition in rheumatoid arthritis fibroblast-like synoviocytes
H. Lv, Y. Li, R. Wang, Y. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/dt5mf6
H. Lv, Y. Li, R. Wang, Y. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/dt5mf6
CER19254
2026,44,5
Pg. 0948-0956
Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus
M.Á. González-Gay, F. Gómez-Bernal, E. Heras-Recuero, J.C. Quevedo-Abeledo, A. De vera-González, B. Tejera-Segura, C. Gómez-Moreno, E. García-Barrera, L.M. Villar, J.G. Ocejo-Vinyals, R. Largo, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/jgz1oz
M.Á. González-Gay, F. Gómez-Bernal, E. Heras-Recuero, J.C. Quevedo-Abeledo, A. De vera-González, B. Tejera-Segura, C. Gómez-Moreno, E. García-Barrera, L.M. Villar, J.G. Ocejo-Vinyals, R. Largo, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/jgz1oz
CER18994
2026,44,5
Pg. 0957-0970
Exploring the comorbidity mechanism of rheumatoid arthritis and systemic lupus erythematosus through transcriptomics and conducting experimental validation
M. Shen, C. You
DOI: https://doi.org/10.55563/clinexprheumatol/1xlydo
M. Shen, C. You
DOI: https://doi.org/10.55563/clinexprheumatol/1xlydo
CER19174
2026,44,5
Pg. 0971-0977
Clinical significance of serum IgE/IgG4 ratio in patients with IgG4-related disease
O.C. Kwon, Y.-B. Park, K.H. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/aus9qq
O.C. Kwon, Y.-B. Park, K.H. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/aus9qq
CER19038
2026,44,5
Pg. 0978-0984
Treatment sequences and lines of therapy in rheumatoid arthritis: a real-world evaluation of retention and effectiveness
M. Movahedi, B. Kuriya, A. Cesta, X. Li, S.Z. Aydin, C. Bombardier, P. Akhavan
on behalf of Ontario Best Practices Initiative (OBRI) Investigators, UHN, Toronto, Canada.
DOI: https://doi.org/10.55563/clinexprheumatol/y1vbr1
M. Movahedi, B. Kuriya, A. Cesta, X. Li, S.Z. Aydin, C. Bombardier, P. Akhavan
on behalf of Ontario Best Practices Initiative (OBRI) Investigators, UHN, Toronto, Canada.
DOI: https://doi.org/10.55563/clinexprheumatol/y1vbr1
CER19339
2026,44,5
Pg. 0985-0995
Drug-induced osteoporosis/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database
Y. Wang, G. Huang, X. Fu, Z. Wang, W. Mao, G. Zheng
DOI: https://doi.org/10.55563/clinexprheumatol/9vqg6f
Y. Wang, G. Huang, X. Fu, Z. Wang, W. Mao, G. Zheng
DOI: https://doi.org/10.55563/clinexprheumatol/9vqg6f
CER18916
2026,44,5
Pg. 0996-1003
Free to view
Three-year follow-up from a randomised controlled trial of a single intra-articular polyacrylamide hydrogel injection in subjects with knee osteoarthritis
H. Bliddal, J. Beier, A. Hartkopp, P.G. Conaghan, M. Henriksen
DOI: https://doi.org/10.55563/clinexprheumatol/5lofry
H. Bliddal, J. Beier, A. Hartkopp, P.G. Conaghan, M. Henriksen
DOI: https://doi.org/10.55563/clinexprheumatol/5lofry
CER19220
2026,44,5
Pg. 1004-1013
Patient clustering by serum inflammatory mediators stratifies early disease-modifying antirheumatic drug-naive rheumatoid arthritis and reveals distinct pathobiological signatures: a prospective observational cohort
G. Kidoguchi, M. Ishitoku, N. Oka, H. Kobayashi, Y. Hosokawa, T. Sugimoto, Y. Yoshida, S. Mokuda, S. Hirata
DOI: https://doi.org/10.55563/clinexprheumatol/bx6ql2
G. Kidoguchi, M. Ishitoku, N. Oka, H. Kobayashi, Y. Hosokawa, T. Sugimoto, Y. Yoshida, S. Mokuda, S. Hirata
DOI: https://doi.org/10.55563/clinexprheumatol/bx6ql2
CER19322
2026,44,5
Pg. 1014-1021
Coexistence of sarcoidosis and spondyloarthritis: a rare but intriguing association
A. Alunno, F. Carubbi, B. De Escalante, G. Policarpo, S. Retamozo, J.S. García Morillo, A. Robles, F. Atzeni, J. Ballano, R. Gómez De La Torre, J.M. Lopez Dupla, M. Ramos-Casals, P. Brito-Zerón
on behalf of the Sjögren Big Data Consortium and the Sarco-GEAS-SEMI Registry
DOI: https://doi.org/10.55563/clinexprheumatol/s678e6
A. Alunno, F. Carubbi, B. De Escalante, G. Policarpo, S. Retamozo, J.S. García Morillo, A. Robles, F. Atzeni, J. Ballano, R. Gómez De La Torre, J.M. Lopez Dupla, M. Ramos-Casals, P. Brito-Zerón
on behalf of the Sjögren Big Data Consortium and the Sarco-GEAS-SEMI Registry
DOI: https://doi.org/10.55563/clinexprheumatol/s678e6
Case Report
CER19669
2026,44,5
Pg. 1022-1024
Clinical and immunologic status of a child conceived following maternal administration of CD19 CAR T-cells for systemic lupus erythematosus
N. Kramer, E.D. Rosenstein, M. Cherry
DOI: https://doi.org/10.55563/clinexprheumatol/g0ehvq
N. Kramer, E.D. Rosenstein, M. Cherry
DOI: https://doi.org/10.55563/clinexprheumatol/g0ehvq
Review
CER18875
2026,44,5
Pg. 1025-1035
Is there place for TNF-alpha inhibitors in the treatment of connective tissue diseases?
A. Matusiewicz, M. Dziewit, S. Ornowska, M. Olesińska
DOI: https://doi.org/10.55563/clinexprheumatol/r24pfo
A. Matusiewicz, M. Dziewit, S. Ornowska, M. Olesińska
DOI: https://doi.org/10.55563/clinexprheumatol/r24pfo
CER19016
2026,44,5
Pg. 1036-1045
The potential role of neutrophils in connective tissue disease-associated interstitial lung disease
H. Wang, Y. Lu, J. Liu, Z. Sang, W. Fan, Y. Liu, J. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/su8rvb
H. Wang, Y. Lu, J. Liu, Z. Sang, W. Fan, Y. Liu, J. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/su8rvb
Paediatric Rheumatology
CER18835
2026,44,5
Pg. 1046-1051
Psoriatic arthritis spectrum in children: a multicentre observational study
S. Pastore, A. Tommasini, G. Martini, A. Pin, A. Taddio, C. Tumminelli, F. Corona, P. Dalena, A. Meneghel, F. Tirelli, F. Dell'apa, M. Fastiggi, M. Cappella, N. Possemato, F. Zulian
S. Pastore, A. Tommasini, G. Martini, A. Pin, A. Taddio, C. Tumminelli, F. Corona, P. Dalena, A. Meneghel, F. Tirelli, F. Dell'apa, M. Fastiggi, M. Cappella, N. Possemato, F. Zulian
Letters to the Editor
CER19357
2026,44,5
Pg. 1052
Free to view
Resolution of refractory systemic lupus erythematosus-associated alopecia with anifrolumab: a case report
G. Buscetta, C. Rizzo, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/udjhxr
G. Buscetta, C. Rizzo, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/udjhxr
CER19627
2026,44,5
Pg. 1053-1054
Free to view
Obinutuzumab in rituximab-refractory or intolerant systemic lupus erythematosus: a real-world case series
E. Firat Senturk, Z. Toker Dincer, A. Karakoc, S. Ugurlu
DOI: https://doi.org/10.55563/clinexprheumatol/dmc85l
E. Firat Senturk, Z. Toker Dincer, A. Karakoc, S. Ugurlu
DOI: https://doi.org/10.55563/clinexprheumatol/dmc85l
Erratum Corrige
CER20113
2026,44,5
Pg. 1055
Free to view
Cardiac involvement in newly diagnosed patients with idiopathic inflammatory myopathies is associated with skeletal muscle involvement
B. Hanna, C.L. Polte, E. Sakiniene, J. Von Brömsen, E. Bollano, I.E. Lundberg, R. Pullerits, T. Jin
DOI: https://doi.org/10.55563/clinexprheumatol/rgybcr
B. Hanna, C.L. Polte, E. Sakiniene, J. Von Brömsen, E. Bollano, I.E. Lundberg, R. Pullerits, T. Jin
DOI: https://doi.org/10.55563/clinexprheumatol/rgybcr
CER20115
2026,44,5
Pg. 1056
Free to view
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry
L. Calabrese, A. Cartocci, A. Vitale, E. Martín-Nares, M. D'onghia, V. Caggiano, J. Torres-Ruiz, R. Lopez, K. Jahnz-Rozyk, K. Rybak, M. Frassi, F. Franceschini, F. Crisafulli, A. Tufan, H. Kucuk, A. Avanoglu Guler, A. Gidaro, L. La Cava, F. Della Casa, I. Mormile, E. Cinotti, G. Lopalco, J. Sota, J. Sbalchiero, G. Emmi, A. Recke, S. Costi, P. Sfriso, S. Monti, O. Viapiana, A. Hinojosa-Azaola, A. Balistreri, C. Fabiani, B. Frediani, P. Rubegni, E. Wiesik-Szewczyk, L. Cantarini
DOI: https://doi.org/10.55563/clinexprheumatol/ys6qle
L. Calabrese, A. Cartocci, A. Vitale, E. Martín-Nares, M. D'onghia, V. Caggiano, J. Torres-Ruiz, R. Lopez, K. Jahnz-Rozyk, K. Rybak, M. Frassi, F. Franceschini, F. Crisafulli, A. Tufan, H. Kucuk, A. Avanoglu Guler, A. Gidaro, L. La Cava, F. Della Casa, I. Mormile, E. Cinotti, G. Lopalco, J. Sota, J. Sbalchiero, G. Emmi, A. Recke, S. Costi, P. Sfriso, S. Monti, O. Viapiana, A. Hinojosa-Azaola, A. Balistreri, C. Fabiani, B. Frediani, P. Rubegni, E. Wiesik-Szewczyk, L. Cantarini
DOI: https://doi.org/10.55563/clinexprheumatol/ys6qle